Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (201-210 of 471) with videos related to

Pageof 48
Sort By:
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Mayo Clinic Proceedings|May 20, 2014
Remission of disseminated cancer after systemic oncolytic virotherapyStephen J Russell, Mark J Federspiel, Kah-Whye Peng, et al.
Frontiers in Immunology|June 25, 2024
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myelomaDoris K Hansen, Binod Dhakal, Mehdi Hamadani, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
British Journal of Haematology|April 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphomaSarah Dingli, Paul Rothweiler, Andre De Menezes Silva Corraes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell TransplantationAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Haematologica|April 21, 2018
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Pageof 48

Showing results (201-210 of 471) with videos related to

Sort By:
Pageof 48
Blood Cancer Journal|November 27, 2021
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Mayo Clinic Proceedings|May 20, 2014
Remission of disseminated cancer after systemic oncolytic virotherapyStephen J Russell, Mark J Federspiel, Kah-Whye Peng, et al.
Frontiers in Immunology|June 25, 2024
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myelomaDoris K Hansen, Binod Dhakal, Mehdi Hamadani, et al.
Blood|September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndromeAnita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
American Journal of Hematology|July 7, 2015
Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myelomaMoritz Binder, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
British Journal of Haematology|April 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphomaSarah Dingli, Paul Rothweiler, Andre De Menezes Silva Corraes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell TransplantationAbdullah S Al Saleh, M Hasib Sidiqi, Eli Muchtar, et al.
Haematologica|April 21, 2018
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Pageof 48